MindMed

Aug 14, 2020

Mind Medicine (MindMed) Inc. Announces Q2 2020 Financial Results

Aug 13, 2020

MindMed Expanding R&D in Europe, Appoints Dr. Miri Halperin Wernli As President

Jun 18, 2020

MindMed To Evaluate Ayahuasca's Active Ingredient DMT In Phase 1 Clinical Trial Collaboration

Apr 22, 2020

Psychedelic Pharmaceutical Company MindMed Develops LSD Neutralizer Technology To Shorten and Stop LSD Trips

Apr 20, 2020

MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations